
    
      Primary Objective: Demonstrate correlation of pre-post reduction in 18F-FTC-146 PET/CT with
      amount of post-treatment tumor necrosis in newly-diagnosed and treated osteosarcoma patients.

      Secondary Objective: Demonstrate correlation of pre-post reduction in 18F-FTC-146 PET/CT with
      amount of post-treatment pain reduction in newly-diagnosed and treated osteosarcoma patients.
    
  